An Illustration of the Potential Health and Economic Benefits of Combating Antibiotic-Resistant Gonorrhea

被引:20
作者
Chesson, Harrell W. [1 ]
Kirkcaldy, Robert D. [1 ]
Gift, Thomas L. [1 ]
Owusu-Edusei, Kwame [1 ]
Weinstock, Hillard S. [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA
关键词
SEXUALLY-TRANSMITTED INFECTIONS; ANTIMICROBIAL RESISTANCE; UNITED-STATES; PREVENTION; COST; MEN;
D O I
10.1097/OLQ.0000000000000725
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Preventing the emergence of ceftriaxone-resistant Neisseria gonorrhoeae can potentially avert hundreds of millions of dollars in direct medical costs of gonorrhea and gonorrhea-attributable HIV infections. In the illustrative scenario we examined, emerging ceftriaxone resistance could lead to 1.2 million additional N. gonorrhoeae infections within 10 years, costing $378.2 million.
引用
收藏
页码:250 / 253
页数:4
相关论文
共 16 条
[1]  
[Anonymous], 2014, NAT STRAT COMB ANT R
[2]  
[Anonymous], 2016, SEX TRANSM DIS SURV
[3]   Core groups, antimicrobial resistance and rebound in gonorrhoea in North America [J].
Chan, Christina H. ;
McCabe, Caitlin J. ;
Fisman, David N. .
SEXUALLY TRANSMITTED INFECTIONS, 2012, 88 (03) :200-204
[4]   Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991-2006 [J].
Chesson, Harrell W. ;
Kirkcaldy, Robert D. ;
Gift, Thomas L. ;
Owusu-Edusei, Kwame, Jr. ;
Weinstock, Hillard S. .
EMERGING INFECTIOUS DISEASES, 2014, 20 (04) :612-619
[5]   Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States [J].
Chesson H.W. ;
Collins D. ;
Koski K. .
Cost Effectiveness and Resource Allocation, 6 (1)
[6]  
Chesson HW, 2000, J ACQ IMMUN DEF SYND, V24, P48
[7]   Antiretroviral Therapy for the Prevention of HIV-1 Transmission [J].
Cohen, M. S. ;
Chen, Y. Q. ;
McCauley, M. ;
Gamble, T. ;
Hosseinipour, M. C. ;
Kumarasamy, N. ;
Hakim, J. G. ;
Kumwenda, J. ;
Grinsztejn, B. ;
Pilotto, J. H. S. ;
Godbole, S. V. ;
Chariyalertsak, S. ;
Santos, B. R. ;
Mayer, K. H. ;
Hoffman, I. F. ;
Eshleman, S. H. ;
Piwowar-Manning, E. ;
Cottle, L. ;
Zhang, X. C. ;
Makhema, J. ;
Mills, L. A. ;
Panchia, R. ;
Faesen, S. ;
Eron, J. ;
Gallant, J. ;
Havlir, D. ;
Swindells, S. ;
Elharrar, V. ;
Burns, D. ;
Taha, T. E. ;
Nielsen-Saines, K. ;
Celentano, D. D. ;
Essex, M. ;
Hudelson, S. E. ;
Redd, A. D. ;
Fleming, T. R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (09) :830-839
[8]   Lifetime Costs and Quality-Adjusted Life Years Saved From HIV Prevention in the Test and Treat Era [J].
Farnham, Paul G. ;
Holtgrave, David R. ;
Gopalappa, Chaitra ;
Hutchinson, Angela B. ;
Sansom, Stephanie L. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 64 (02) :E15-E18
[9]   Antibiotic-Resistant Neisseria gonorrhoeae Spread Faster with More Treatment, Not More Sexual Partners [J].
Fingerhuth, Stephanie M. ;
Bonhoeffer, Sebastian ;
Low, Nicola ;
Althaus, Christian L. .
PLOS PATHOGENS, 2016, 12 (05)
[10]   The role of compensatory mutations in the emergence of drug resistance [J].
Handel, Andreas ;
Regoes, Roland R. ;
Antia, Rustom .
PLOS COMPUTATIONAL BIOLOGY, 2006, 2 (10) :1262-1270